Next Article in Journal
The Pathway for New Cancer Drug Access in Canada
Previous Article in Journal
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study
Guidelines

Models of Follow-Up Care and Secondary Prevention Measures for Survivors of Colorectal Cancer: Evidence-Based Guidelines and Systematic Review

1
Queen’s University Cancer Research Institute, Division of Cancer Care and Epidemiology, Queen’s University, Kingston, ON K7L 3N6, Canada
2
Program in Evidence-Based Care, McMaster University, Hamilton, ON L8S 4L8, Canada
3
Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
4
Ottawa Hospital Cancer Centre, The Hospital General Campus, Ottawa, ON K1H 8L6, Canada
5
Southlake Regional Cancer Centre, Newmarket, ON L3Y 2P9, Canada
6
Dorval Medical FHT, Oakville, ON L6K 3W6, Canada
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2022, 29(2), 439-454; https://doi.org/10.3390/curroncol29020040
Received: 29 November 2021 / Revised: 14 January 2022 / Accepted: 16 January 2022 / Published: 19 January 2022
Objective: To provide recommendations for preferred models of follow-up care for stage I-IV colorectal (CRC) cancer survivors in Ontario; to identify signs and symptoms of potential recurrence and when to investigate; and to evaluate patient information and support needs during the post-treatment survivorship period. Methods: Consistent with the Program in Evidence-Based Medicine’s standardized approach, MEDLINE, EMBASE, PubMed, Cochrane Library, and PROSPERO databases were systematically searched. The authors drafted recommendations and revised them based on the comments from internal and external reviewers. Results: Four guidelines, three systematic reviews, three randomized controlled trials, and three cohort studies provided evidence to develop recommendations. Conclusions: Colorectal cancer follow-up care is complex and requires multidisciplinary, coordinated care delivered by the cancer specialist, primary care provider, and allied health professionals. While there is limited evidence to support a shared care model for follow-up, this approach is deemed to be best suited to meet patient needs; however, the roles and responsibilities of care providers need to be clearly defined, and patients need to know when and how to contact them. Although there is insufficient evidence to recommend any individual or combination of signs or symptoms as strong predictor(s) of recurrence, patients should be educated about these and know which care provider to contact if they develop any new or concerning symptoms. Psychosocial support and empathetic, effective, and coordinated communication are most valued by patients for their post-treatment follow-up care. Continuing professional education should emphasize the importance of communication skills and coordination of communication between the patient, family, and healthcare providers. View Full-Text
Keywords: colorectal cancer; surveillance; follow-up; survivorship; support needs colorectal cancer; surveillance; follow-up; survivorship; support needs
Show Figures

Figure 1

MDPI and ACS Style

Galica, J.; Zwaal, C.; Kennedy, E.; Asmis, T.; Cho, C.; Ginty, A.; Govindarajan, A. Models of Follow-Up Care and Secondary Prevention Measures for Survivors of Colorectal Cancer: Evidence-Based Guidelines and Systematic Review. Curr. Oncol. 2022, 29, 439-454. https://doi.org/10.3390/curroncol29020040

AMA Style

Galica J, Zwaal C, Kennedy E, Asmis T, Cho C, Ginty A, Govindarajan A. Models of Follow-Up Care and Secondary Prevention Measures for Survivors of Colorectal Cancer: Evidence-Based Guidelines and Systematic Review. Current Oncology. 2022; 29(2):439-454. https://doi.org/10.3390/curroncol29020040

Chicago/Turabian Style

Galica, Jacqueline, Caroline Zwaal, Erin Kennedy, Tim Asmis, Charles Cho, Alexandra Ginty, and Anand Govindarajan. 2022. "Models of Follow-Up Care and Secondary Prevention Measures for Survivors of Colorectal Cancer: Evidence-Based Guidelines and Systematic Review" Current Oncology 29, no. 2: 439-454. https://doi.org/10.3390/curroncol29020040

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop